COVID Vaccine Strategy Still Murky After FDA Experts Meet

June 29, 2022

(Axios) – The COVID-19 vaccine strategy for the fall remains beset with unanswered questions after an FDA expert panel on Tuesday spent hours debating how and whether to update the shots. Why it matters: Time is running short to develop a game plan with existing vaccines losing effectiveness against new variants and more than half of Americans still without a booster dose. (Read More)